Document is current
Any future updates will be listed below
-
Authors
Wilhelmi, Tim https://orcid.org/0009-0008-2400-2840
Bartsch, Vanessa https://orcid.org/0000-0001-6029-2103
Platt, Marius
Rashid, Asarnusch
Hornig, Johannes
Krusche, Martin
Hueber, Axel J
Fink, Daniel
Pfeil, Alexander
Dischereit, Gabriel
Holzer, Marie-Therese
Drott, Ulrich
Aries, Peer
Müller, Max
Böhm, Peter
Morf, Harriet
Labinsky, Hannah
Mühlensiepen, Felix
Benavent, Diego
Kuhn, Sebastian
Klemm, Philipp https://orcid.org/0000-0001-7911-4235
Knitza, Johannes https://orcid.org/0000-0001-9695-0657
-
Funding
Funding for this research was provided by:
Horizon Europe grant for the SPIDERR project (101080711)
Horizon Europe grant for the SPIDERR project (101080711)
Deutsche Rheumastiftung
- License Information
-
More Information
Article History
Received: 1 July 2026
Accepted: 29 September 2026
First Online: 5 October 2026
Declarations
Ethics Approval: The Ethics Committee of Philipps University Marburg classified this study as exempt from ethical approval (reference: 25-237-Anz).
Consent to Participate: Participation was voluntary. Completion of the questionnaire and use of the chatbot implied informed consent to participate.
Consent for Publication: Not applicable.
Competing interests: A.R. is employed by Zentrum für Telemedizin Bad Kissingen. All other authors declare that they have no competing interests.
Clinical Trial Number: Not applicable.
AI Declaration: During the preparation of this manuscript, the authors used ChatGPT (OpenAI) and Claude (Anthropic) to assist with language editing and text refinement. All AI-generated output was critically reviewed, verified, and revised by the authors, who take full responsibility for the final content of the manuscript. Large language models were also used as part of the study methodology, as described in the Methods section.
